title: Diabetes mellitus is a strong negative prognostic factor in patients with myocardial infarction treated with thrombolytic therapy.
abstract: OBJECTIVE
  To assess the long-term prognostic values of baseline demographic data, occurrence of vectorcardiographic signs of reperfusion, left ventricular function and coronary angiographic features.
  
  
  METHODS
  Longitudinal study of morbidity and mortality.
  
  
  METHODS
  Coronary care unit at Danderyd Hospital, Stockholm, Sweden.
  
  
  METHODS
  A total of 222 patients (mean age 61 years) with a suspected acute myocardial infarction treated with thrombolysis were investigated and followed for 2-5 years (mean 1216 days).
  
  
  METHODS
  Death or a new myocardial infarction.
  
  
  RESULTS
  Age above 55 years (P < 0.05), a previous diagnosis of diabetes mellitus (P < 0.005), hypertension (P < 0.05), heart failure (P < 0.001) and myocardial infarction (P < 0.05), a previous use of beta-blockers (P < 0.05) and an ejection fraction below 60% (P < 0.01) were predictors for death or a new myocardial infarction in univariate analysis. Sex, a previous history of smoking or angina pectoris, vectorcardiographic signs of reperfusion or degree of coronary artery disease had no prognostic values. In multivariate analysis including age above 55 years, a previous diagnosis of diabetes mellitus, hypertension and myocardial infarction, and an ejection fraction below 60%, only age (P < 0.05), diabetes mellitus (P < 0. 01) and ejection fraction (P < 0.05) were predictors for death or a new myocardial infarction.
  
  
  CONCLUSIONS
  The results of the present study emphasize the importance of diabetes mellitus as a long-term prognostic risk factor in patients with myocardial infarction treated with thrombolysis. Further studies are needed to determine the mechanisms behind this increased risk.
authors.affiliation: Department of Internal Medicine, Norrtälje Hospital, Stockholm, Sweden.
authors.forename: L E
authors.initials: LE
authors.lastname: Strandberg
authors.forename: C G
authors.initials: CG
authors.lastname: Ericsson
authors.forename: M L
authors.initials: ML
authors.lastname: O'Konor
authors.forename: L
authors.initials: L
authors.lastname: Bergstrand
authors.forename: P
authors.initials: P
authors.lastname: Lundin
authors.forename: N
authors.initials: N
authors.lastname: Rehnqvist
authors.forename: P
authors.initials: P
authors.lastname: Tornvall
mesh_terms: D000368:Aged; D003925:Diabetic Angiopathies / Q000188:drug therapy* / Q000401:mortality; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality; D011379:Prognosis; D016019:Survival Analysis; D015912:Thrombolytic Therapy; D014672:Vectorcardiography